Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort Oumarou Nabi, Jonas Spaak, Göran Bergström, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P. Andersson, Hannes Hagström Journal of Internal Medicine.2026; 299(4): 481. CrossRef
Resveratrol dual efficacy in high-altitude hypoxia and NAFLD: inhibits ferroptosis by modulating key proteins, including HIF-1α, ACSL4, and TfR1 Minghui Zhao, Hongfang Mu, Qian Ji, Jiale Song, Fuyixuan Zheng, Tianlong Liu, Wenbin Li, Rong Wang Phytomedicine.2026; 153: 157992. CrossRef
Association of serum uric acid and serum uric acid/creatinine ratio with metabolic dysfunction-associated fatty liver disease in young adults: a retrospective study Yue Li, Zixian Li, Siyu Wu, Ling Cao, Beibei Qian, Junxian Tao, Zhimin Qian, Li Xie, Xiaoli Cai, Xiaofang Sun, Ying Li, Zhenwen Zhang, Caifeng Yan, Dunmin She BMC Endocrine Disorders.2026;[Epub] CrossRef
MASLD In Children - A Distinct Phenotype? Pervej Alom Barbhuiya, Manash Pratim Pathak Current Obesity Reports.2026;[Epub] CrossRef
Use of Hepatoscope 2DTE for non-invasive assessment of liver stiffness among Mexican immigrant adults in a community-based setting Edgar A. Villavicencio, Cindy Serdjebi, Adriana Maldonado, Estefania Ochoa Mora, Adrien Besson, Naim Alkhouri, David O. Garcia Clinics and Research in Hepatology and Gastroenterology.2025; 49(5): 102581. CrossRef
Frailty and MASLD in the Arab region: An urgent call for regional clinical and public health strategies Mohamed El-Kassas, Khalid Alswat, Asma Labidi, Maen Almattooq, Doaa Zakaria, Nabil Debzi, Faisal M Sanai, Mohamed Elbadry, Ali Tumi, Imam Waked, Abdel-Naser Elzouki, Khalid M. AlNaamani Arab Journal of Gastroenterology.2025; 26(4): 315. CrossRef
Dietary Interventions in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review of Evidence, Mechanisms, and Translational Challenges Alejandra Paredes-Marin, Yulu He, Xiaotao Zhang Nutrients.2025; 17(21): 3491. CrossRef
Research and clinical trial design in patients with metabolic dysfunction and alcohol-associated steatotic liver disease (MetALD): a narrative review Pedro Acuña, Omar Albhaisi, Francisco Idalsoaga, Naim Alkhouri, Mazen Noureddin, Luis Antonio Díaz, Juan Pablo Arab Metabolism and Target Organ Damage.2025;[Epub] CrossRef
Correspondence to editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study” Vy H. Nguyen, Mindie H. Nguyen Clinical and Molecular Hepatology.2024; 30(4): 1000. CrossRef
Reply to correspondence on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study” Jae Hyun Bae Clinical and Molecular Hepatology.2024; 30(4): 1047. CrossRef
First
Prev
